Active, not recruitingPhase 1NCT07200986

Study to Compare Pharmacokinetics and Safety of CT-P52 and US-licensed Taltz in Healthy Subjects

Studying Anorectal malformation

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Celltrion
Intervention
Ixekizumab(biological)
Enrollment
218 target
Eligibility
19-55 years · All sexes
Timeline
20252026

Study locations (5)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07200986 on ClinicalTrials.gov

Other trials for Anorectal malformation

Additional recruiting or active studies for the same condition.

See all trials for Anorectal malformation

← Back to all trials